Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NN | CTOS |
|---|---|---|
| Price | $13.32 | $9.88 |
| Change today | ▼ 4.72% | ▲ 1.02% |
| Market cap | $2.25B | $2.25B |
| Return, 3 months | -21.1% | +3.2% |
| Return, year to date | -20.0% | +71.5% |
| Return, 1 year | -9.6% | +52.9% |
| P/E (TTM) | -16.2 | 109.8 |
| P/B | 6.7 | 2.8 |
| P/E percentile vs own 5y | 10th | 99th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -4.3% | – |
| Net profit growth (YoY) | +46.6% | – |
| Gross margin | -104.9% | – |
| Operating margin | -1,900.4% | – |
| Net margin | -2,812.5% | – |
| Return on equity | -77.9% | – |
| Analyst target vs. price | +72.7% | +31.6% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 38 | 59 |
| 30-day volatility | 60.8% | 35.4% |
| Max drawdown, 1 year | -47.3% | -26.4% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
